Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial-Reference-Cited by-同舟云学术

Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial

Published:2017-06 Issue:2 Volume:22 Page:149-152
ISSN:1085-9489
Container-title:Journal of the Peripheral Nervous System
language:en
Short-container-title:J Peripher Nerv Syst

Author:

Merkies Ingemar S. J.¹,Lawo John-Philip²,Edelman Jonathan M.³,De Bleecker Jan L.⁴,Sommer Claudia⁵,Robberecht Wim⁶,Saarela Mika⁷,Kamienowski Jerzy⁸,Stelmasiak Zbigniew⁹,Mielke Orell²,Tackenberg Björn¹⁰,Léger Jean-Marc¹¹,

Affiliation:

1. Spaarne Hospital; Hoofddorp, and Maastricht University Medical Centre; Maastricht The Netherlands

2. CSL Behring GmbH; Marburg Germany

3. CSL Behring LLC; King of Prussia PA USA

4. AZ St-Lucas; Gent Belgium

5. Department of Neurology; Universitätsklinikum Würzburg; Würzburg Germany

6. UZ Leuven; Leuven Belgium

7. Department of Neurology; Helsinki University Central Hospital; Helsinki Finland

8. Dolnośląski Szpital Specjalistyczny; Wroclaw Poland

9. Samodzielny Publiczny Szpital Kliniczny; Lublin Poland

10. Department of Neurology; Philipps University; Marburg Germany

11. Reference Center for Rare Neuromuscular Diseases; Hôpital Pitié-Salpêtrière, and University Paris VI; Paris France

Publisher

Wiley

Subject

Clinical Neurology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jns.12204/fullpdf

Reference19 articles.

1. Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness;Draak;Neurology,2014

2. Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses;Draak;J Peripher Nerv Syst,2015

3. Using Rasch modeling to re-evaluate three scales related to physical activity: enjoyment, perceived benefits and perceived barriers;Heesch;Health Educ Res,2006

4. Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods;Hobart;Health Technol Assess,2009

5. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy;Hughes;Ann Neurol,2001

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimal Clinically Important Difference (MCID) in Patient-Reported Outcome Measures for Neurological Conditions: Review of Concept and Methods;Annals of Indian Academy of Neurology;2023

2. Rituximab in chronic immune mediated neuropathies: a systematic review;Neuromuscular Disorders;2022-08

3. Role of altered IL‐33/ST2 immune axis in the immunobiology of Guillain‐Barré syndrome;European Journal of Neurology;2022-04-12

4. Variations within Toll‐like receptor ( TLR ) and TLR signaling pathway‐related genes and their synergistic effects on the risk of Guillain‐Barré syndrome;Journal of the Peripheral Nervous System;2022-02-23

5. Prognostic value of neurofilament light chain in chronic inflammatory demyelinating polyneuropathy;Brain Communications;2021